Using CpG as an optimal TLR9 agonist and focusing on early events after virus infection, we found that after pDC activation more of the pDC chromatin landscape is "turned on" rather than "turned off“, both globally in the genome and also among the regions associated with TF genes themselves. The gene discussed is TLR9; the disease is viral infectious disease.